MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Data Visualization Tool to Improve Interpretation of MDS-UPDRS Results Post-DBS

C. van Horne, G. Quintero, J. Hixson (Lexington, USA)

Meeting: 2025 International Congress

Keywords: Deep brain stimulation (DBS), Scales

Category: Parkinson's Disease: Surgical Therapy

Objective: To evaluate the potential of our previously developed data visualization platform for the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) as a tool for assessing the efficacy of interventions in Parkinson’s disease.

Background: Previously, we developed a novel data visualization platform that organizes Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) scores into intuitive, anatomically-oriented displays (cited in reference). We demonstrated it utility in displaying meaningful levels of severity and changes to medication durign ON/OFF testing. We have expanded its utility to the evaluation of DBS outcomes.

Method: We applied the visualization tool to a 71-year-old female with tremor-predominant Parkinson’s disease, who underwent bilateral STN DBS, comparing her baseline MDS-UPDRS scores to her 6-month postoperative evaluation. The key to the visualization scale is shown in [1,2]

Results: The visualization tool displayed MDS-UPDRS Parts I–IV scores in an anatomically-oriented, color-coded format, comparing baseline (E1) with 6-month postoperative scores (E2) off medication and on stimulation. The change visualization indicated symptom improvements (green and blue) and worsening (yellow to red), highlighting clinically meaningful improvements post-DBS, particularly in tremor-related areas [3]. This patient had a good response overall.  The tool can highlight areas in other patients who have incomplete improvements for targeting stimulation or medication adjustments.

Conclusion: Our visualization tool effectively demonstrates clinically meaningful changes in MDS-UPDRS scores following DBS intervention. Based on this display, clinicians can readily identify areas requiring therapeutic adjustments, either through medication or stimulation changes. This method also demonstrates the potential to fully leverage the MDS-UPDRS for tracking longitudinal therapeutic outcomes across various interventions in Parkinson’s disease.

Figure 1

Figure 1

Figure 2

Figure 2

Figure 3

Figure 3

References: Hixson J, Quintero JE, Guiliani A, Yamasaki TR, Gerhardt GA, Slevin JT, van Horne CG. Visualization of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale Results. J Parkinsons Dis. 2023;13(3):421-426. doi: 10.3233/JPD-225071. PMID: 36938741; PMCID: PMC10200163.

To cite this abstract in AMA style:

C. van Horne, G. Quintero, J. Hixson. A Data Visualization Tool to Improve Interpretation of MDS-UPDRS Results Post-DBS [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/a-data-visualization-tool-to-improve-interpretation-of-mds-updrs-results-post-dbs/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-data-visualization-tool-to-improve-interpretation-of-mds-updrs-results-post-dbs/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley